Amylyx Pharmaceuticals’ (AMLX) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report issued on Wednesday morning,Benzinga reports. They currently have a $12.00 target price on the stock. HC Wainwright also issued estimates for Amylyx Pharmaceuticals’ Q1 2025 earnings at ($0.43) EPS, Q2 2025 earnings at ($0.43) EPS, Q3 2025 […]
HC Wainwright reissued their buy rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report issued on Wednesday morning,Benzinga reports. They currently have a $12.00 target price on the stock. HC Wainwright also issued estimates for Amylyx Pharmaceuticals’ Q1 2025 earnings at ($0.43) EPS, Q2 2025 earnings at ($0.43) EPS, Q3 2025 […]
